This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/domain/vavai/projekt/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/ontology/domain/vavai/
n15http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68378050%3A_____%2F03%3A23033192%21RIV%2F2004%2FGA0%2FA23004%2FN/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n4http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68378050%3A_____%2F03%3A23033192%21RIV%2F2004%2FGA0%2FA23004%2FN
rdf:type
n14:Vysledek skos:Concept
dcterms:description
Attention should be paid to the MHC class I status of neoplasms during the design of immunotherapy protocols. For therapy of MHC class I deficient tumours, cytokines such as IFN gamma, IL-12, IL-2, GM-CSF, either exogenous or produced by gene-modified vaccines, should be considered. The therapeutic role of the induction of MHC class I expression by demethylation and acetylation agents should also be investigated. Attention should be paid to the MHC class I status of neoplasms during the design of immunotherapy protocols. For therapy of MHC class I deficient tumours, cytokines such as IFN gamma, IL-12, IL-2, GM-CSF, either exogenous or produced by gene-modified vaccines, should be considered. The therapeutic role of the induction of MHC class I expression by demethylation and acetylation agents should also be investigated.
dcterms:title
MHC class I status of tumours and design of immunotherapeutic strategies. MHC class I status of tumours and design of immunotherapeutic strategies.
skos:prefLabel
MHC class I status of tumours and design of immunotherapeutic strategies. MHC class I status of tumours and design of immunotherapeutic strategies.
skos:notation
RIV/68378050:_____/03:23033192!RIV/2004/GA0/A23004/N
n3:strany
177;178
n3:aktivita
n7:Z n7:P
n3:aktivity
P(GA301/01/0985), P(IAA5052203), P(NC6957), P(NC7148), P(NC7552), Z(AV0Z5052915)
n3:cisloPeriodika
2-3
n3:dodaniDat
n4:2004
n3:domaciTvurceVysledku
n6:6215319
n3:druhVysledku
n9:J
n3:duvernostUdaju
n18:S
n3:entitaPredkladatele
n17:predkladatel
n3:idSjednocenehoVysledku
615368
n3:idVysledku
RIV/68378050:_____/03:23033192
n3:jazykVysledku
n10:eng
n3:klicovaSlova
MHC; beta2-mikroglobulin; immunotherapeutic strategies
n3:klicoveSlovo
n11:beta2-mikroglobulin n11:immunotherapeutic%20strategies n11:MHC
n3:kodStatuVydavatele
NL - Nizozemsko
n3:kontrolniKodProRIV
[5015A8E6BFBE]
n3:nazevZdroje
Immunology Letters
n3:obor
n16:FB
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
2
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n8:GA301%2F01%2F0985 n8:NC7148 n8:IAA5052203 n8:NC6957 n8:NC7552
n3:rokUplatneniVysledku
n4:2003
n3:svazekPeriodika
90
n3:tvurceVysledku
Bubeník, Jan Vonka, V.
n3:zamer
n15:AV0Z5052915
s:issn
0165-2478
s:numberOfPages
2